These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 30981471)

  • 21. Treatment of Perinatal Opioid Use Disorder.
    Boyars L; Guille C
    Obstet Gynecol Clin North Am; 2018 Sep; 45(3):511-524. PubMed ID: 30092925
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Opioid Exposed Mothers and Infants in Delaware: Clinical and Legal Considerations.
    Savin MK; Paul DA
    Del Med J; 2016 Apr; 88(4):110-4. PubMed ID: 27263243
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trends of Neonatal Abstinence Syndrome Epidemic and Maternal Risk Factors in Florida.
    Wang X; Zhu Y; Dave CV; Alrwisan AA; Voils SA; Winterstein AG
    Pharmacotherapy; 2017 Jul; 37(7):806-813. PubMed ID: 28500694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. On "Rise in Neonatal Abstinence Syndrome Rate Is Associated with Increase in Buprenorphine Prescription Numbers".
    Ghodasara SK; Yang HJ; Nemeth ZH
    South Med J; 2024 Aug; 117(8):510. PubMed ID: 39094803
    [No Abstract]   [Full Text] [Related]  

  • 25. Rates of Neonatal Abstinence Syndrome Amid Efforts to Combat the Opioid Abuse Epidemic.
    Brown JD; Doshi PA; Pauly NJ; Talbert JC
    JAMA Pediatr; 2016 Nov; 170(11):1110-1112. PubMed ID: 27669331
    [No Abstract]   [Full Text] [Related]  

  • 26. Caring for Opioid-dependent Pregnant Women: Prenatal and Postpartum Care Considerations.
    Krans EE; Cochran G; Bogen DL
    Clin Obstet Gynecol; 2015 Jun; 58(2):370-9. PubMed ID: 25775440
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of psychiatric medication co-exposure on Neonatal Abstinence Syndrome severity.
    Wachman EM; Warden AH; Thomas Z; Thomas-Lewis JA; Shrestha H; Nikita FNU; Shaw D; Saia K; Schiff DM
    Drug Alcohol Depend; 2018 Nov; 192():45-50. PubMed ID: 30205307
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analgesia, Opioids, and Other Drug Use During Pregnancy and Neonatal Abstinence Syndrome.
    Jones HE; Kraft WK
    Clin Perinatol; 2019 Jun; 46(2):349-366. PubMed ID: 31010564
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Maternity Care for Pregnant Women with Opioid Use Disorder: A Review.
    Rizk AH; Simonsen SE; Roberts L; Taylor-Swanson L; Lemoine JB; Smid M
    J Midwifery Womens Health; 2019 Sep; 64(5):532-544. PubMed ID: 31407485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beyond the Treatment Box: Perspectives on the Federal Response to Opioid Use, Pregnancy, and Neonatal Abstinence Syndrome.
    Terplan M
    J Addict Med; 2017; 11(3):176-177. PubMed ID: 28406855
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Opioid Use Disorder and Pregnancy.
    O'Donnell FT; Jackson DL
    Mo Med; 2017; 114(3):181-186. PubMed ID: 30228577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Implications of Tennessee's Opioid Legislation for Neonatal Abstinence Syndrome.
    Shearer JN; Erwin PC; Davis SK; Anderson JG; Lindley LC
    Policy Polit Nurs Pract; 2019 Aug; 20(3):153-162. PubMed ID: 31390304
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Buprenorphine and methadone for opioid addiction during pregnancy.
    Mozurkewich EL; Rayburn WF
    Obstet Gynecol Clin North Am; 2014 Jun; 41(2):241-53. PubMed ID: 24845488
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Breastfeeding and the United States Opioid Epidemic.
    Eidelman AI
    Breastfeed Med; 2018 May; 13(4):229. PubMed ID: 29638144
    [No Abstract]   [Full Text] [Related]  

  • 35. Rural and Urban Differences in Neonatal Abstinence Syndrome and Maternal Opioid Use, 2004 to 2013.
    Villapiano NL; Winkelman TN; Kozhimannil KB; Davis MM; Patrick SW
    JAMA Pediatr; 2017 Feb; 171(2):194-196. PubMed ID: 27942711
    [No Abstract]   [Full Text] [Related]  

  • 36. Prevalence of Prenatal Opioid Exposure in Ontario, Canada, 2014-2019.
    Camden A; Ray JG; To T; Gomes T; Bai L; Guttmann A
    JAMA Netw Open; 2021 Feb; 4(2):e2037388. PubMed ID: 33595660
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neonatal Opioid Withdrawal Syndrome (NOWS): A Transgenerational Echo of the Opioid Crisis.
    Weller AE; Crist RC; Reiner BC; Doyle GA; Berrettini WH
    Cold Spring Harb Perspect Med; 2021 Mar; 11(3):. PubMed ID: 32229609
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between prenatal opioid exposure, neonatal opioid withdrawal syndrome, and neurodevelopmental and behavioral outcomes at 5-8 months of age.
    Bakhireva LN; Holbrook BD; Shrestha S; Leyva Y; Ashley M; Cano S; Lowe J; Stephen JM; Leeman L
    Early Hum Dev; 2019 Jan; 128():69-76. PubMed ID: 30554024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methadone, Buprenorphine, and Naltrexone for the Treatment of Opioid Use Disorder in Pregnant Women.
    Tran TH; Griffin BL; Stone RH; Vest KM; Todd TJ
    Pharmacotherapy; 2017 Jul; 37(7):824-839. PubMed ID: 28543191
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fetal Outcomes with Detoxification from Opioid Drugs during Pregnancy: A Systematic Review.
    Towers CV; Terry P; Rackley B; Hennessy M; Visconti K
    Am J Perinatol; 2020 Jun; 37(7):679-688. PubMed ID: 31104311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.